Literature DB >> 29031851

Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.

Jaakko Kopra1, Marian Villarta-Aguilera1, Mari Savolainen1, Samo Weingerl1, Timo T Myöhänen1, Saara Rannanpää1, Michael F Salvatore2, Jaan-Olle Andressoo3, T Petteri Piepponen4.   

Abstract

Addictive drugs enhance dopamine release in the striatum, which can lead to compulsive drug-seeking after repeated exposure. Glial cell line-derived neurotrophic factor (GDNF) is an important regulator of midbrain dopamine neurons, and may play a mechanistic role in addiction-related behaviors. To elucidate the components of GDNF-signaling that contribute to addiction-related behaviors of place preference and its extinction, we utilized two genetically modified GDNF mouse models in an amphetamine-induced conditioned place preference (CPP) paradigm and evaluated how the behavioral findings correlate with dopamine signaling in the dorsal and ventral striatum. We utilized two knock-in mouse strains to delineate contributions of GDNF and Ret signaling using MEN2B mice (constitutively active GDNF receptor Ret), and GDNF hypermorphic mice (enhanced endogenous GDNF expression). The duration of amphetamine-induced CPP was greatly enhanced in MEN2B mice, but not in the GDNF hypermorphic mice. The enhanced duration of CPP was correlated with increased tyrosine hydroxylase (TH) expression and dopamine content in the ventral striatum. Together, our results suggest that downstream components of GDNF signaling, in this case Ret, may mediate persistent drug-seeking behavior through increased TH expression and dopamine levels in the mesolimbic dopamine neurons.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amphetamine; Conditioned place preference; Dopamine; GDNF; MEN2B; Striatum

Mesh:

Substances:

Year:  2017        PMID: 29031851      PMCID: PMC6104196          DOI: 10.1016/j.neuropharm.2017.10.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  40 in total

1.  An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.

Authors:  Minae Niwa; Atsumi Nitta; Yuichiro Yamada; Akira Nakajima; Kuniaki Saito; Mitsuru Seishima; Liya Shen; Yukihiro Noda; Shoei Furukawa; Toshitaka Nabeshima
Journal:  Biol Psychiatry       Date:  2006-10-13       Impact factor: 13.382

2.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra.

Authors:  Jelena Mijatovic; Mikko Airavaara; Anu Planken; Petri Auvinen; Atso Raasmaja; T Petteri Piepponen; Frank Costantini; Liisa Ahtee; Mart Saarma
Journal:  J Neurosci       Date:  2007-05-02       Impact factor: 6.167

4.  Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area.

Authors:  Michael F Salvatore; Brandon S Pruett; Charles Dempsey; Victoria Fields
Journal:  J Vis Exp       Date:  2012-08-10       Impact factor: 1.355

5.  Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.

Authors:  Michael F Salvatore; Jin-Lu Zhang; Delia M Large; Patsy E Wilson; Clelland R Gash; Theresa Currier Thomas; John W Haycock; Guoying Bing; John A Stanford; Don M Gash; Greg A Gerhardt
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

6.  Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals.

Authors:  Jelena Mijatovic; Marjo Piltonen; Paolo Alberton; Pekka T Männistö; Mart Saarma; T Petteri Piepponen
Journal:  Neurobiol Aging       Date:  2009-09-20       Impact factor: 4.673

7.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.

Authors:  K D Beck; J Valverde; T Alexi; K Poulsen; B Moffat; R A Vandlen; A Rosenthal; F Hefti
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

8.  Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.

Authors:  Jelena Mijatovic; Outi Patrikainen; Leonid Yavich; Mikko Airavaara; Liisa Ahtee; Mart Saarma; T Petteri Piepponen
Journal:  J Neurochem       Date:  2008-02-01       Impact factor: 5.372

Review 9.  Apparatus bias and place conditioning with ethanol in mice.

Authors:  Christopher L Cunningham; Nikole K Ferree; MacKenzie A Howard
Journal:  Psychopharmacology (Berl)       Date:  2003-10-30       Impact factor: 4.530

10.  Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.

Authors:  Michael F Salvatore; Greg A Gerhardt; Robert D Dayton; Ronald L Klein; John A Stanford
Journal:  Exp Neurol       Date:  2009-05-19       Impact factor: 5.330

View more
  3 in total

1.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

2.  MicroRNA miR-27b-3p regulate microglial inflammation response and cell apoptosis by inhibiting A20 (TNF-α-induced protein 3).

Authors:  Liping Li; Chao Qi; Yuanyuan Liu; Youliang Shen; Xia Zhao; Han Qin; Yi Zhang; Tengbo Yu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Two-fold elevation of endogenous GDNF levels in mice improves motor coordination without causing side-effects.

Authors:  Kärt Mätlik; Vootele Võikar; Carolina Vilenius; Natalia Kulesskaya; Jaan-Olle Andressoo
Journal:  Sci Rep       Date:  2018-08-08       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.